A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
In this study, we modify an existing experimental method to obtain more reproducible results, by establishing a middle cerebral artery occlusion (MCAO) mouse model. Oral administration of Glycyrrhizae Radix et Rhizome (GR) methanol extract (GRex), following stroke induction, significantly decreased total infarction volume relative to the untreated control group.
Ischemia followed by reperfusion of cerebral blood flow after a stroke leads to the death of nerve cells and loss of brain tissue. The most commonly used animal model for studying stroke is the middle cerebral artery occlusion (MCAO) model. Previous research studies have reported different infarct sizes even when the same experimental animal species was used under similar MCAO conditions. Therefore, we developed an improved experimental method to address this discrepancy. Mice were subjected to MCAO using a filament as the occlusion material to mimic human stroke conditions and filament thickness was optimized to establish more reproducible infarction volume. Mice treated with a methanol extract of Glycyrrhizae Radix et Rhizome (GRex) following stroke induction showed a significantly decreased total infarction volume and increased number of surviving cells relative to the untreated control group. This modified experimental protocol successfully and reproducibly demonstrated the beneficial effect of GRex on ischemic stroke.
Brain damage caused by ischemia and reperfusion of cerebral blood flow leads to the death of nerve cells and loss of brain tissue. This type of brain damage continues to increase with the increasing prevalence of cerebrovascular diseases due to the spread of metabolic diseases such as obesity, hypertension, and diabetes mellitus1,2. The absolute number of elderly patients with stroke has dramatically increased worldwide, and the cost of medical care for these patients, who are often left with long-term disabilities, is a major societal burden. Therefore, secondary disabilities should be mitigated as much as possible to reduce the economic burden1,2.
The most commonly used rodent model of cerebral infarction is the middle cerebral artery (MCA) occlusion (MCAO) model, in which the MCA is occluded with a silicon-coated surgical suturing filament to block blood flow, causing ischemic stroke3,4. Using a filament as the occlusion material allows the control of occlusion time and permanence by manipulating the duration of the intra-luminal filament insertion.
Previous studies have shown that even when the same rodent MCAO model is used, the total volume of cerebral infarction varies between experiments, causing low reproducibility of the studies. To improve reproducibility, we optimized the thickness of the filament mint used in the experiment. The results of a preliminary study of the cerebral ischemic period and induced infarction showed that an ischemic period longer than 60 min allowed the volumetric region of damaged brain tissue to be observed and quantified.
Glycyrrhizae Radix et Rhizoma (GR), also known as licorice, consists of the dried roots and rhizomes of Glycyrrhiza uralensis and G. glabra. It has been used in Chinese and Korean traditional medicine for various purposes including as a food additive and medicinally5,6,7.
In a previous study8, pre-treatment with GR methanol extract (GRex) showed an anti-apoptotic effect in MCAO mice, including significant prevention of the decrease in the protein expression of B-cell lymphoma 2 (Bcl-2) and Bcl extra-large (Bcl-xL). This study was conducted to improve the reproducibility of the conventional MCAO mouse model by evaluating its efficiency in determining if post-infarct treatment with GRex effectively reduced the infarct volume in MCAO-induced cerebral damage.
All procedures involving animals were approved by the ethics committee of Pusan National University (approval number, PNU-2016-1087). A graphical overview of this study is shown in Figure 1.
1. Preparation and Administration of GRex
NOTE: The GR used in this study was purchased from a commercial pharmaceutical company.
2. Mouse Model of MCAO
3. Measurement of Volume of Damaged Brain Tissue
4. Hematoxylin and Eosin (H&E) and Cresyl Violet Staining of Histological Sections
5. Statistical Analysis
In the sham-operated normal group, no cerebral infarct is observed whereas in the control group, a relatively wide range of damaged areas is observed. In the mice administered 300 mg/kg GRex in the MCAO model group, a statistically significant reduction in damaged area is observed (Figure 2).
The histological changes are investigated by staining ischemic brain sections with H&E or cresyl violet....
With the increasing prevalence of metabolic diseases such as chronic hypertension, diabetes, and hyperlipidemia, which are major risk factors for stroke, stroke prevention and treatment have become an important area of medical research12,13. Deficits in language and movement after a stroke are strongly correlated with the degree of damage to brain tissue14 and result in a poor quality of life for patients and their families
The authors have nothing to disclose.
Not applicable.
Name | Company | Catalog Number | Comments |
Glycyrrhizae Radix et Rhizoma | Gwangmyoung Pharmaceuticals Co., Korea | Glycyrrhizae Radix et Rhizoma | |
Qualitative filter paper | Advantec | Filter paper No. 2 | Qualitative filter paper |
Dimethyl sulfoxide (DMSO) | Sigma | D8418-250ML | Dimethyl sulfoxide (DMSO) |
Syringe filter (0.45 µm) | Sigma | CLS431220 | Syringe filter (0.45 µm) |
Stereo Microscope | Leica | M50 | Stereo Microscope |
Stereo Microscope | Nikon | SMZ745 | Stereo Microscope |
Laser Doppler | Moor Instrument | moorVMS-LDF | Laser Doppler |
Anesthesia Tabletop Bracket with N2O&O2 Flowmeter System | Harvard Appratus | 34-1352 | Anesthesia Tabletop Bracket with N2O&O2 Flowmeter System |
Homeothermic Monitoring System | Harvard Appratus | 55-7020 | Homeothermic Monitoring System |
Digital Camera | Canon | Eos-M2 | Digital Camera |
Cryostat | Leica | CM3050S | Cryostat |
Microscope | Carl Zeiss | Zeiss Axio | Microscope |
Data Analysis | Systat Software Inc. | SigmaPlot version 12 | Data Analysis |
Data Analysis | NIH Image | ImageJ | Data Analysis |
Mouse diet | Doo Yeol Biotech | Standard rodent chow | Mouse diet |
Isoflurane | JOONGWAE | A02104781 | Isoflurane |
Isoflurane | TROIKAA | ISOTROY 100 | Isoflurane |
Silk suture (4-0 Black silk) | AILEE | SK47510 | Silk suture (4-0 Black silk) |
Silk suture (3-0 White silk) | Baekjae | 57 | Silk suture (3-0 White silk) |
Nylon suture (8-0 monofilament) | AILEE | NB825 | Nylon suture (8-0 monofilament) |
2,3,5-triphenyltetrazolium chloride (TTC) | Sigma | T8877-25G | 2,3,5-triphenyltetrazolium chloride (TTC) |
Formalin (Formaldehyde solution) | JUNSEI | 69360-1263 20KG | Formalin (Formaldehyde solution) |
Hematoxylin (Harris Hematoxylin) | YD Diagnostics | EasyStain | Hematoxylin (Harris Hematoxylin) |
Eosin (1% Eosin Y Solution) | MUTO PURE CHEMICALS | 3200-2 | Eosin (1% Eosin Y Solution) |
Cresyl violet (acetate) | Sigma | C5042-10G | Cresyl violet (acetate) |
Paraformaldehyde | Sigma-Aldrich | P6148-1KG | Paraformaldehyde |
Sucrose | JUNSEI | 31365-0350 1KG | Sucrose |
Optimum cutting temperature (OCT) compound | Scigen | 4583 | Optimum cutting temperature (OCT) compound |
Disecting Knife | Fine Science Tools | 10055-12 | Disecting Knife |
#4 Forcep | Fine Science Tools | 11241-30 | #4 Forcep |
#5 Forcep | Fine Science Tools | 11254-20 | #5 Forcep |
#6 Forcep | Fine Science Tools | 11260-20 | #6 Forcep |
#7 Fine Forcep | Fine Science Tools | 11274-20 | #7 Fine Forcep |
Surgical Scissors | Fine Science Tools | 14001-12 | Surgical Scissors |
Extra Fine Bonn Scissors | Fine Science Tools | 14084-08 | Extra Fine Bonn Scissors |
Moria Pascheff-Wolff Spring Scissors | Fine Science Tools | 15371-92 | Moria Pascheff-Wolff Spring Scissors |
Vessel Dilating Forcep | Fine Science Tools | 18153-11 | Vessel Dilating Forcep |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved